Medicine and Dentistry
Ganglioglioma
100%
Neoplasm
70%
Pediatrics
51%
Neurofibromatosis Type I
34%
Oligoastrocytoma
30%
microRNA
30%
Glioblastoma
30%
Cell Differentiation
20%
DNA Repair
18%
Subependymal Giant Cell Astrocytoma
17%
Neural Stem Cell
17%
microRNA 125b
15%
Glutathione
15%
Severe Myoclonic Epilepsy of Infancy
15%
RNA Binding Protein
15%
microRNA 10b
15%
Telomere
15%
Carcinogenicity
15%
Phosphotransferase Inhibitor
15%
Programmed Death-Ligand 1
15%
Vascularity
15%
MEK Inhibitor
15%
Carboplatin
15%
Radiosensitivity
15%
Granular Cell
15%
Everolimus
13%
Central Nervous System Tumor
12%
Glioma Cell Line
12%
In Vitro
10%
Cell Growth
10%
Xenograft
9%
Cell Culture
9%
Cell Migration
8%
Next Generation Sequencing
8%
Pilocytic Astrocytoma
7%
Cell Line
6%
Trametinib
6%
Sapanisertib
6%
Brain Tumor
6%
Immunohistochemistry
6%
Pleomorphic Xanthoastrocytoma
6%
Rho Kinase
6%
Fibroblast
6%
Cancer Stem Cell
5%
Cell Death
5%
Programmed Cell Death
5%
Neuroepithelioma
5%
Quantitative Reverse Transcription Polymerase Chain Reaction
5%
Ganglioside GM2
5%
Translational Neuroscience
5%
Biochemistry, Genetics and Molecular Biology
Alpha Thalassemia/Mental Retardation X-Linked
46%
Yersinia
35%
RNA-binding Protein
30%
Telomere
30%
Cellular Differentiation
20%
Non-Homologous End Joining
19%
MEK Inhibitor
17%
Target Cell
15%
IDH1
15%
Molecular Genetics
15%
Radiosensitivity
15%
Vascularization
15%
Cell Adhesion
15%
Actin-Binding Protein
15%
Lysosomal Storage Disease
15%
PRC2
15%
Channelopathy
15%
Synapsin I
15%
Phosphotransferase
15%
Kinase
15%
Adhesion Structure
15%
DNA Damage Response
15%
Subependymal Giant Cell Astrocytoma
15%
DNA Repair
15%
Binding Protein
15%
Fibroblast
15%
Tay-Sachs Disease
15%
Stem Cell
15%
Trametinib
15%
Cell Migration
12%
Overall Survival
11%
Cancer Stem Cell
11%
Corepressor
10%
BCL6
10%
Binding Domain
9%
Cell Growth
9%
MRN Complex
7%
Janus Kinase 1
7%
Epidermal Growth Factor Receptor
7%
OLIG2
7%
H3F3A
7%
Next Generation Sequencing
7%
CD68
7%
Cytogenetics
7%
Glutamatergic
7%
Mouse Model
7%
Signal Recognition Particle Receptor
7%
Infancy
7%
Monosomy
7%
PALB2
7%
Keyphrases
Pediatric Low-grade Glioma
46%
RBM14
30%
Tumor
21%
MicroRNA-10b
15%
Diffuse Glioma
15%
Carboplatin
15%
Non-homologous End Joining
15%
In(III)
15%
IDH-wildtype
15%
Glutathione
15%
Mammalian Target of Rapamycin (mTOR)
15%
Granular Cell Tumor
15%
YopH
15%
Synergize
15%
Molecular Genetic Features
15%
RNA-binding Protein
15%
BCOR ITD
15%
Mutational Status
15%
Neural Stem Cells
15%
MicroRNA-125b
15%
Dissociation
15%
BRAF V600E
15%
Promoting Growth
15%
Internal Tandem Duplication
15%
MiR-487b
15%
Primary Glioblastoma
15%
Polycomb Repressive Complex 2 (PRC2)
15%
PD-L1 Expression
15%
Cell Growth
15%
Cell Invasion
15%
Everolimus
13%
Overexpression
10%
DNA Damage
9%
Programmed Death-ligand 1 (PD-L1)
7%
Dravet Syndrome
7%
DNA Damage Response
7%
Chromatin
7%
Glioma Cell Lines
6%
Granular Cells
6%
Cell Morphology
6%
Pilocytic Astrocytoma
5%
Apoptosis
5%
MRN Complex
5%
Low-grade Glioma
5%
Polycomb Repressive Complex 1 (PRC1)
5%
PD-1 Pathway
5%
BCL6 Corepressor
5%
Central Nervous System Tumors
5%
Immunohistochemistry
5%
